title: Neurological complications during treatment of childhood cancer: mind Wernicke encephalopathy.
authors.forename: Milena
authors.initials: M
authors.lastname: La Spina
authors.forename: Roberta
authors.initials: R
authors.lastname: Catania
authors.forename: Luca
authors.initials: L
authors.lastname: Lo Nigro
authors.forename: Carlo
authors.initials: C
authors.lastname: De Grandi
authors.forename: Stefano
authors.initials: S
authors.lastname: Palmucci
authors.forename: Andrea
authors.initials: A
authors.lastname: Di Cataldo
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects*; D001215:Asparaginase / Q000008:administration & dosage / Q000009:adverse effects; D002648:Child; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects; D003561:Cytarabine / Q000008:administration & dosage / Q000009:adverse effects; D003630:Daunorubicin / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000000981:diagnostic imaging / Q000188:drug therapy*; D008279:Magnetic Resonance Imaging; D008297:Male; D015122:Mercaptopurine / Q000008:administration & dosage / Q000009:adverse effects; D008727:Methotrexate / Q000008:administration & dosage / Q000009:adverse effects; D011241:Prednisone / Q000008:administration & dosage / Q000009:adverse effects; D011859:Radiography; D014750:Vincristine / Q000008:administration & dosage / Q000009:adverse effects; D014899:Wernicke Encephalopathy / Q000139:chemically induced* / Q000000981:diagnostic imaging / Q000188:drug therapy
chemical_list: D003561:Cytarabine; D014750:Vincristine; D003520:Cyclophosphamide; D015122:Mercaptopurine; D001215:Asparaginase; D011241:Prednisone; D008727:Methotrexate; D003630:Daunorubicin